Picture of SolGold logo

SOLG SolGold News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeSmall CapMomentum Trap

REG - SolGold PLC - Final Results <Origin Href="QuoteRef">SOLG.L</Origin> - Part 5

- Part 5: For the preceding part double click  ID:nRSN7272Qd 

 203,169      780,168        168,353        
 
 
Other receivables represent funds receivable from the exercise of share options, Australian Goods and Services Tax
receivable and an advance made to a landowner in Ecuador. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 16 CASH AND CASH EQUIVALENTS 
 
                                                           Group2017A$  Group2016A$  Company2017A$  Company2016A$  
 Cash at bank                                              89,312,743   94,933       88,669,626     17,199         
 Cash and cash equivalents in the statement of cash flows  89,312,743   94,933       88,669,626     17,199         
 
 
NOTE 17 CAPITAL AND RESERVES 
 
(a) Authorised Share Capital 
 
                                                                         2016No. of Shares  2016Nominal Value £  
 At 1 July 2015 - Ordinary shares                                        1,020,000,000      10,200,000           
 Increase in authorised share capital of £0.01 each on 27 November 2015  400,000,000        4,000,000            
 At 30 June 2016 - Ordinary shares                                       1,420,000,000      14,200,000           
 
 
                                                                        2017No. of Shares  2017Nominal Value £  
 At 1 July 2016 - Ordinary shares                                       1,420,000,000      14,200,000           
 Increase in authorised share capital of £0.01 each on 13 October 2016  600,000,000        6,000,000            
 At 30 June 2017 - Ordinary shares                                      2,020,000,000      20,200,000           
 
 
(b) Changes in Issued Share Capital and Share Premium 
 
                                                                      No. of Shares  Nominal ValueA$  Share PremiumA$  Total A$     
 Ordinary shares of 1p each at 1 July 2015                            760,453,071    13,184,721       82,212,310       95,397,031   
 Shares issued at £0.015 - Placement 19 November 2015                 62,263,534     1,331,612        665,807          1,997,419    
 Share issue costs charged to share premium account                   -              -                (16,161)         (16,161)     
 Shares issued at £0.023 - Placement 7 March 2016                     80,909,257     1,541,129        2,003,467        3,544,596    
 Shares issued at £0.023 - Convertible notes conversion 7 March 2016  50,271,739     957,557          2,623,084        3,580,641    
 Ordinary shares of 1p at 30 June 2016                                953,897,601    17,015,019       87,488,507       104,503,526  
 
 
                                                                No. of Shares  Nominal ValueA$  Share PremiumA$  Total A$     
 Ordinary shares of 1p each at 30 June 16                       953,897,601    17,015,019       87,488,507       104,503,526  
 Shares issued at £0.06 - Placement 28 August 20161             268,819,004    4,654,961        23,274,286       27,929,248   
 Share issue costs charged to share premium account             -              -                (4,696,253)      (4,696,253)  
 Shares issued at £0.13 - Placement 17 October 20162            206,250,000    3,298,144        40,426,856       43,725,000   
 Share issue costs charged to share premium account             -              -                (1,706,552)      (1,706,552)  
 Shares issued at £0.14 - Exercise of options 17 January 2017   900,000        14,499           178,820          193,319      
 Shares issued at £0.30 - Newcrest share issue 31 January 2017  100,000        1,660            47,949           49,609       
 Shares issued at £0.14 - Exercise of options 3 February 2017   1,200,000      19,804           257,457          277,261      
 Shares issued at £0.14 - Exercise of options 21 February 2017  900,000        14,582           189,646          204,228      
 Shares issued at £0.38 - Newcrest share issue 1 March 2017     240,000        3,885            145,201          149,086      
 Shares issued at £0.41 - Placement 16 June 2017                78,889,080     1,324,161        53,197,804       54,521,966   
 Share issue costs charged to share premium account             -              -                (72,269)         (72,269)     
 Shares issued at £0.14 - Exercise of options 26 June 2017      880,000        14,775           192,070          206,844      
 Shares issued at £0.28 - Exercise of options 26 June 2017      880,000        14,775           398,914          413,688      
 Ordinary shares of 1p at 30 June 2017                          1,512,955,685  26,376,265       199,322,436      225,698,701  
 
 
1 Includes the conversion of the DGR Global Ltd loan of A$5,700,000, conversion of capital raising costs of A$1,221,614,
other debt conversions of A$86,359 and bonus shares issued to certain staff of A$519,481 as part of the share placement. 
 
2 Includes conversion of capital raising costs of A$1,660,751 as part of the share placement. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 17 CAPITAL AND RESERVES (continued) 
 
Capital Management 
 
Management controls the capital of the Group in order to generate long-term shareholder value and ensure that the Group can
fund operations and continue as a going concern.  Management effectively manages the Group's capital by assessing the
Group's financial risks and adjusting its capital structure in response to changes in these risks and in the market.  These
responses include share issues and debt considerations. Given the nature of the Group's current activities the entity will
remain dependant on equity funding in the short to medium term until such time as the Group becomes self-financing from the
commercial production of mineral resources. 
 
NOTE 18 TRADE AND OTHER CURRENT PAYABLES 
 
                   Group2017A$  Group2016A$  Company2017A$  Company2016A$  
 Current                                                                   
 Trade payables    569,569      1,348,875    437,409        847,413        
 Other payables    1,950,716    351,145      228,603        56,958         
 Accrued expenses  220,890      2,042,341    94,362         312,473        
                   2,741,175    3,742,361    760,374        1,216,844      
 
 
NOTE 19 SHARE OPTIONS 
 
At 30 June 2017 the Company had 44,191,768 options outstanding for the issue of ordinary shares (2016: 21,380,000). 
 
Options 
 
Share options are granted to employees under the company's Employee Share Option Plan ("ESOP").  The employee share option
plan is designed to align participants' interests with those of shareholders. 
 
Unless otherwise documented with the Company, when a participant ceases employment prior to the vesting of their share
options, the share options are forfeited after 90 days unless cessation of employment is due to termination for cause,
whereupon they are forfeited immediately. The Company prohibits key management personnel from entering into arrangements to
protect the value of unvested ESOP awards. 
 
The contractual life of each option granted is generally two (2) to three (3) years. There are no cash settlement
alternatives. 
 
Each option can be exercised from vesting date to expiry date for one share with the exercise price payable in cash. 
 
Share options issued 
 
There were 41,591,768 options granted during the year ended 30 June 2017 (2016: nil). 
 
On 17 October 2016, the Company issued an additional 19,591,768 unlisted options to Maxit Capital LP. The options consist
of two tranches of 9,795,884 options each exercisable at £0.14 and £0.28. 
 
On 28 October 2016, the Company issued a total of 22,000,000 unlisted options to employees and contractors. The options
have a strike price of £0.28 each and are exercisable through to 28 October 2018. 
 
On 8 July 2014, the Company entered into an agreement to grant 4,360,000 unlisted options to the Board of Directors. The
options have a life of 3 years.  The terms of the share options are as follows: 
 
·      2.18 million Options exercisable at £0.14, vesting once the Company's share price has traded at a minimum of £0.20
on a 30 day VWAP basis; 
 
·      2.18 million Options exercisable at £0.28, vesting once the Company's share price has traded at a minimum of £0.40
on a 30 day VWAP basis; and 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 19 SHARE OPTIONS (continued) 
 
 Date of grant     Exercisable from                                                                                                                                         Exercisable to    Exercise prices  Number granted      Number at 30 June 2017  
 10 May 2013*      When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis                                                                   6 September 2017  £0.14            3,000,000           -                       
 8 July 2014       When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis                                                                   8 July 2017       £0.14            2,180,000           1,300,000               
 8 July 2014       When the Company's share price has traded at a minimum of £0.40 on a 30 day VWAP basis                                                                   8 July 2017       £0.28            2,180,000           1,300,000               
 17 October 2016   The options vested immediately, through to 17 October 2018                                                                                               17 October 2018   £0.14£0.28       9,795,8849,795,884  9,795,8849,795,884      
 17 November 2016  The options vest on the earlier of:(a) the expiry of 75% of the Term, or (b) a Change of Control Transaction, as defined under the Company's ESOP Rules  28 October 2018   £0.28            22,000,000          22,000,000              
                                                                                                                                                                                                               48,951,688          44,191,768              
 
 
 Date of grant      Exercisable from                                                                        Exercisable to     Exercise prices  Number granted  Number at 30 June 2016  
 10 May 2013*       When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis  6 September 2017   £0.14            3,000,000       3,000,000               
 15 July 2013       When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis  15 July 2016       £0.14            1,250,000       1,250,000               
 15 July 2013       When the Company's share price has traded at a minimum of £0.40 on a 30 day VWAP basis  15 July 2016       £0.28            2,250,000       2,250,000               
 15 July 2013       When the Company's share price has traded at a minimum of £0.80 on a 30 day VWAP basis  15 July 2016       £0.50            4,000,000       4,000,000               
 24 September 2013  When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis  24 September 2016  £0.14            3,250,000       2,850,000               
 24 September 2013  When the Company's share price has traded at a minimum of £0.40 on a 30 day VWAP basis  24 September 2016  £0.28            3,250,000       2,850,000               
 24 September 2013  When the Company's share price has traded at a minimum of £0.80 on a 30 day VWAP basis  24 September 2016  £0.50            820,000         820,000                 
 8 July 2014        When the Company's share price has traded at a minimum of £0.20 on a 30 day VWAP basis  8 July 2017        £0.14            2,180,000       2,180,000               
 8 July 2014        When the Company's share price has traded at a minimum of £0.40 on a 30 day VWAP basis  8 July 2017        £0.28            2,180,000       2,180,000               
                                                                                                                                                22,180,000      21,380,000              
 
 
*The options were granted for accounting purposes on 10 May 2013, approved at the Annual General Meeting held on 19 August
2013 and formally allotted on 6 September 2013. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 19 SHARE OPTIONS (continued) 
 
Share-based payments 
 
The number and weighted average exercise price of share options are as follows: 
 
                                           Weighted average exercise price2017  Number of options2017  Weighted average exercise price2016  Number of options2016  
 Outstanding at the beginning of the year  £0.27                                21,380,000             £0.27                                21,380,000             
 Exercised during the year                 £0.17                                (4,760,000)                                                                        
 Lapsed during the year                    £0.31                                (14,020,000)           -                                                           
 Granted during the year                   £0.25                                41,591,768             -                                                           
 Outstanding at the end of the year        £0.25                                44,191,768             £0.27                                21,380,000             
 Exercisable at the end of the year        £0.21                                22,191,768             -                                    -                      
 
 
The options outstanding at 30 June 2017 have an exercise price of £0.14 and £0.28 (2016: £0.14 - £0.50) and a weighted
average contractual life of 1.24 years (2016: 0.46 years). 
 
Share options held by Directors are as follows: 
 
 Nicholas Mather  750,000  750,000  14p  08/07/14 - 08/07/17  
                  750,000  750,000  28p  08/07/14 - 08/07/17  
 Brian Moller     550,000  550,000  14p  08/07/14 - 08/07/17  
                  550,000  550,000  28p  08/07/14 - 08/07/17  
 Robert Weinberg  -        440,000  14p  08/07/14 - 08/07/17  
                  -        440,000  28p  08/07/14 - 08/07/17  
 John Bovard      -        440,000  14p  08/07/14 - 08/07/17  
                  -        440,000  28p  08/07/14 - 08/07/17  
 
 
08/07/14 - 08/07/17 
 
- 
 
440,000 
 
28p 
 
08/07/14 - 08/07/17 
 
The total number of options outstanding at year end is as follows: 
 
 Share options heldat 30 June 2017  Share options heldat 30 June 2016  Option price  Exercise periods                                                                                                                                   
 -                                  3,000,000                          £0.14         Vesting from 30 day VWAP of 20p to 06/09/2017                                                                                                      
 -                                  1,250,000                          £0.14         Vesting from 30 day VWAP of 20p to 15/07/2016                                                                                                      
 -                                  2,250,000                          £0.28         Vesting from 30 Day VWAP of 40p to 15/07/2016                                                                                                      
 -                                  4,000,000                          £0.50         Vesting from 30 Day VWAP of 80p to 15/07/2016                                                                                                      
 -                                  2,850,000                          £0.14         Vesting from 30 Day VWAP of 20p to 24/09/2016                                                                                                      
 -                                  2,850,000                          £0.28         Vesting from 30 Day VWAP of 40p to 24/09/2016                                                                                                      
 -                                  820,000                            £0.50         Vesting from 30 Day VWAP of 80p to 24/09/2016                                                                                                      
 1,300,000                          2,180,000                          £0.14         Vesting from 30 Day VWAP of 20p to 08/07/2017                                                                                                      
 1,300,000                          2,180,000                          £0.28         Vesting from 30 Day VWAP of 40p to 08/07/2017                                                                                                      
 9,795,884                          -                                  £0.14         Exercisable through to 17/10/2018                                                                                                                  
 9,795,884                          -                                  £0.28         Exercisable through to 17/10/2018                                                                                                                  
 22,000,000                         -                                  £0.28         Vests on the earlier of the expiry of 75% of the term of the option or a Change of Control Transaction, as defined under the Company's ESOP Rules  
 44,191,768                         21,380,000                                                                                                                                                                                          
 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 19 SHARE OPTIONS (continued) 
 
Share-based payments (continued) 
 
The fair value of services received in return for share options granted is measured by reference to the fair value of share
options granted.  This estimate is based on either a Black-Scholes model or Monte Carlo Simulation considering the effects
of the vesting conditions, expected exercise period and the dividend policy of the Company. 
 
                                                                               2017                          
 Fair value of share options and assumptions                                   £0.14 Options17 October 2016  £0.28 Options17 October 2016  £0.28 Options28 October 2016  
 Number of options                                                             9,795,884                     9,795,884                     22,000,000                    
 Fair value at issue date                                                      £0.12                         £0.09                         £0.14                         
 Exercise price                                                                £0.14                         £0.28                         £0.28                         
 Expected volatility                                                           99.744%                       99.744%                       99.744%                       
 Option life                                                                   2.00 years                    2.00 years                    2.00 years                    
 Expected dividends                                                            0.00%                         0.00%                         0.00%                         
 Risk-free interest rate (short-term)                                          0.53%                         0.53%                         0.66%                         
 Valuation methodology                                                         Black-Scholes                 Black-Scholes                 Black-Scholes                 
                                                                                                                                                                         
                                                                               A$                            A$                            A$                            
 Share based payments expense recognised in statement of comprehensive income  -                             -                             2,158,840                     
 Share based payments expense recognised as share issue costs                  1,912,810                     1,393,000                     -                             
 Share based payments expense to be recognised in future periods               -                             -                             2,062,000                     
 
 
 Fair value of share options and assumptions  Prior year grants         
                                              £0.14 Options8 July 2014  £0.28 Options8 July 2014  
 Number of options                            2,180,000                 2,180,000                 
 Fair value at issue date                     £0.010                    £0.003                    
 Exercise price                               £0.140                    £0.280                    
 Expected volatility                          115.31%                   115.31%                   
 Option life                                  3.00 years                3.00 years                
 Expected dividends                           0.00%                     0.00%                     
 Risk-free interest rate (short-term)         2.48%                     2.48%                     
 Valuation methodology                        Monte Carlo               Monte Carlo               
 
 
The calculation of the volatility of the share price was based on the Company's daily closing share price over the two-year
period prior to the date the options were issued. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 20 FINANCIAL INSTRUMENTS (GROUP AND COMPANY) 
 
Financial instruments by category (Group) 
 
 Financial assets                               Loans and receivables  Available-for-sale  
                                                2017                   2016                2017        2016       
 Cash and cash equivalents                      89,312,743             94,933              -           -          
 Trade and other receivables                    1,086,331              123,974             -           -          
 Loans receivable and other non-current assets  226,175                123,974             -           -          
 Equity investments                             -                      -                   14,366,304  1,622,712  
 Total financial assets                         90,625,249             342,881             14,366,304  1,622,712  
 
 
 Financial liabilities        Financial liabilities at amortised cost  
                              2017                                     2016       
 Trade and other payables     2,741,175                                3,742,361  
 Borrowings                   -                                        4,776,404  
 Total financial liabilities  2,741,175                                8,518,765  
 
 
Financial instruments by category (Company) 
 
 Financial assets                               Loans and receivables  Available-for-sale  
                                                2017                   2016                2017        2016       
 Cash and cash equivalents                      88,669,626             17,199              -           -          
 Trade and other receivables                    689,248                168,353             -           -          
 Loans receivable and other non-current assets  90,137                 -                   -           -          
 Equity investments                             -                      -                   14,360,725  1,617,132  
 Total financial assets                         89,449,011             185,552             14,360,725  1,617,132  
 
 
 Financial liabilities        Financial liabilities at amortised cost  
                              2017                                     2016       
 Trade and other payables     760,374                                  1,216,844  
 Borrowings                   -                                        4,776,404  
 Total financial liabilities  760,374                                  5,993,248  
 
 
If required, the Board of Directors determines the degree to which it is appropriate to use financial instruments,
commodity contracts or other hedging contracts or techniques to mitigate risks.  The main risks for which such instruments
may be appropriate are foreign currency risk and liquidity risk, each of which is discussed below.  The main credit risk is
the non-collection of loans and other receivables which include refunds and tenement security deposits. There were no
overdue receivables at year end. 
 
For the Company, the main credit risk is the non-collection of loans made to its subsidiaries. The Directors expect to
collect the loans through the successful exploration and subsequent exploitation of the subsidiaries' tenements. 
 
There have been no changes in financial risks from the previous year. 
 
During the year ended 30 June 2017 and 2016 no trading in commodity contracts was undertaken. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 20 FINANCIAL INSTRUMENTS (GROUP AND COMPANY) (continued) 
 
Market risk 
 
Interest rate risks 
 
The Group's and Company's policy is to retain its surplus funds on the most advantageous term of deposit available up to
twelve month's maximum duration. The increase/decrease of 2% in interest rates will impact the Group's income statement by
a gain/loss of A$1,786,268 and the company's income statement by A$1,773,406. The group considers that a 2% +/- movement
interest rates represent reasonable possible changes. 
 
Foreign currency risk 
 
The Group has potential currency exposures in respect of items denominated in foreign currencies comprising: 
 
§ Transactional exposure in respect of operating costs, capital expenditures and, to a lesser extent, sales incurred in
currencies other than the functional currency of operations which require funds to be maintained in currencies other than
the functional currency of operation; and 
 
§ Translation exposures in respect of investments in overseas operations which have functional currencies other than
Australian dollars. 
 
Currency risk in respect of non-functional currency expenditure is reviewed by the Board. 
 
The table below shows the extent to which Group companies have monetary assets and liabilities in different currencies. 
Foreign exchange differences on retranslation of such assets and liabilities are taken to the statement of comprehensive
income. 
 
                                     Functional currency of entity  
 Net Financial Assets (Liabilities)  AUD                            USD  SBD  TOTAL       
 2017                                                                                     
 Australian dollar                   -                              -    -    -           
 United States dollar (USD)          86,554,253                     -    -    86,554,253  
 Solomon Island dollar (SBD)         14,746                         -    -    14,746      
 Great British Pound (GBP)           173,926                        -    -    173,926     
                                     86,742,925                     -    -    86,742,925  
 
 
                                     Functional currency of entity  
 Net Financial Assets (Liabilities)  AUD                            USD  SBD  TOTAL      
 2016                                                                                    
 Australian dollar                   -                              -    -    -          
 United States dollar (USD)          (33,499)                       -    -    (33,499)   
 Solomon Island dollar (SBD)         -                              -    -    -          
 Great British Pound (GBP)           (136,999)                      -    -    (136,999)  
                                     (170,498)                      -    -    (170,498)  
 
 
The main currency exposure relates to the effect of re-translation of the Group's assets and liabilities in Solomon Island
dollar (SBD), United States dollar (USD) and the Great British Pound (GBP).  A 10% increase in the SBD/A$, USD/A$ and
GBP/A$ exchange rates would give rise to a change of approximately A$9,638,103 (2016: A$18,781) in the Group net assets and
reported earnings. A 10% decrease in the SBD/A$, USD/A$ and GBP/A$ exchange rates would give rise to a change of
approximately A$7,885,720 (2016: A$15,366), The Group does not hedge foreign currency exposures and manages net exposures
by buying and selling foreign currencies at spot rates where necessary. In respect of other monetary assets and liabilities
held in currencies other than Australian dollars, the Group ensures that the net exposure is kept to an acceptable level,
by buying or selling foreign currencies at spot rates where necessary to address short-term imbalances. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 20 FINANCIAL INSTRUMENTS (GROUP AND COMPANY) (continued) 
 
Credit Risk 
 
The Group is exposed to credit risk primarily from the financial institutions with which it holds cash and cash deposits. 
The banks and their credit ratings the Group had cash accounts with at 30 June 2017 were A$1,653,814 in cash accounts with
Macquarie Bank Limited (BBB) in Australia, A$22,611 in cash accounts with the ANZ Bank (AA-) in Australia, A$86,952,457 in
cash accounts with Westpac Bank (AA-) in Australia, A$14,749 in cash accounts with the ANZ Bank (AA-) in Honiara, Solomon
Islands, A$463,312 in cash accounts with Banco Guayaquil (AAA-) in Ecuador, A$372 in cash accounts with Banco Pichincha (B)
in Ecuador, A$129,866 in cash accounts with Produbanco (B) in Ecuador and A$75,571 in petty cash.  Including other
receivables, the maximum exposure to credit risk at the reporting date was A$90,388,769 (2016: A$298,102). 
 
The company is also exposed to credit risk due to the cash balances it holds directly.  It is also exposed to credit risk
on the loan balances it holds with its subsidiaries. At 30 June 2017, the company had A$88,669,626 in cash and cash
equivalents and A$55,302,853 of intercompany loan balances receivable.  The maximum exposure to credit risk at the
reporting date was A$143,973,144. 
 
Credit risk is managed by dealing with banks with high credit ratings assigned by international credit rating agencies. 
Furthermore, funds are deposited with banks of high standing in order to obtain market interest rates. 
 
Liquidity risks 
 
The Group and Company raises funds as required on the basis of budgeted expenditure for the next 12 to 24 months, dependent
on a number of prevailing factors. Funds are generally raised in capital markets from a variety of eligible private,
corporate and fund investors, or from interested third parties (including other exploration and mining companies) which may
be interested in earning an interest in the project. The success or otherwise of such capital raisings is dependent upon a
variety of factors including general equities and metals market sentiment, macro-economic outlook, project prospectivity,
operational risks and other factors from time to time.  When funds are sought, the Group balances the costs and benefits of
equity financing. Funds are provided to local sites bi-monthly, based on the sites' forecast expenditure. 
 
All liabilities held by the Group are contractually due and payable within 1 year. 
 
Fair values 
 
In the Directors' opinion, with the exception of available for sale assets, there is no material difference between the
book value and fair value of any of the Group's and Company's financial instruments. The classes of financial instruments
are the same as the line items included on the face of the statement of financial position and have been analysed in more
detail in notes to the accounts. 
 
All the Group's financial assets, with the exception of available for sale assets are categorised as loans and receivables
and all financial liabilities are measured at amortised cost. 
 
NOTE 21 COMMITMENTS 
 
The Group also has certain obligations to expend minimum amounts on exploration in tenement areas.  These obligations may
be varied from time to time and are expected to be fulfilled in the normal course of operations of the Group. 
 
The combined commitments of the Group related to its granted tenement interests are as follows: 
 
 Location         Up to 12 Months  13 Months to 5 Years  Later than 5 Years  
 Ecuador          1,019,748        5,098,739             -                   
 Solomon Islands  -                -                     -                   
 Queensland       556,000          40,000                -                   
                  1,575,748        5,138,739             -                   
 
 
To keep tenements in good standing, work programs should meet certain minimum expenditure requirements.  If the minimum
expenditure requirements are not met, the Group has the option to negotiate new terms or relinquish the tenements.  The
Group also has the ability to meet expenditure requirements by joint venture or farm in agreements. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 22 RELATED PARTIES 
 
(a) Group 
 
Transactions between related parties are on normal commercial terms and conditions no more favourable than those available
to other parties unless otherwise stated. 
 
a)            Transactions with Directors and Director-Related Entities 
 
(i)                      The Company had a commercial agreement with Samuel Capital Ltd ("Samuel") for the engagement of
Nicholas Mather as director of the Company.  For the year ended 30 June 2017 A$416,667 was paid or payable to Samuel (2016:
A$150,000).  These amounts are included in Note 5 (Remuneration of Key Management Personnel).  The total amount outstanding
at year end is A$26,725 (2016: A$62,500). 
 
(ii)                     The Company has a long-standing commercial arrangement with DGR Global Ltd, an entity associated
with Nicholas Mather (Director) and Brian Moller (Director), for the provision of various services, whereby DGR Global
provides resources and services including the provision of its administration and exploration staff, its premises (for the
purposes of conducting the Company's business operations), use of existing office furniture, equipment and certain
stationery, together with general telephone, reception and other office facilities (''Services'').  In consideration for
the provision of the Services, the Company shall reimburse DGR Global for any expenses incurred by it in providing the
Services.  For the year ended 30 June 2017 A$360,000 was paid or payable to DGR Global (2016: A$360,000) for the provision
of administration, management and office facilities to the Company during the year.  The total amount outstanding at year
end was A$22,011 (2016: A$120,000). 
 
(iii)                   Mr Brian Moller (a Director), is a partner in the Australian firm HopgoodGanim lawyers.  For the
year ended 30 June 2017, HopgoodGanim were paid A$459,325 (2016: A$66,263) for the provision of legal services to the
Company.  The services were based on normal commercial terms and conditions.  The total amount outstanding at year end was
A$92,350 (2016: A$66,263). 
 
(iv)                    On 20 November 2015, DGR Global Ltd agreed to provide short term funding to SolGold plc to provide
working capital. Interest on the facility was charged at the rate of 9.5% per annum. The loan was repayable by SolGold plc
on the earlier of any capital raising event, or 31 December 2016. DGR Global Ltd could, at its sole election, convert all
or part of the loan, including accrued interest, into further equity as part of a SolGold plc capital raising, and at the
same price as third party participants, subject to DGR Global Ltd and SolGold plc obtaining all necessary regulatory
approvals. A new loan agreement was signed on 30 June 2016 revising the limit on the facility to A$7 million, all other
conditions remained the same. On 29 August 2016, DGR Global Ltd converted A$5,700,000 of the debt funding provided to
SolGold into SolGold shares in accordance with the terms of the loan arrangements announced to the market on 1 July 2016. 
 
(v)                      On 2 October 2015, DGR Global Ltd and Tenstar Trading Ltd agreed to provide short term funding to
SolGold PLC to provide working capital. Interest on the facility was charged at 9.5% per annum. The loans were repayable by
SolGold 12 months from the date of issue. DGR Global Ltd and Tenstar Trading Ltd could, at their sole election, convert all
or part of the loan, including accrued interest, into further equity at either 1.75 pence (GBP) or a price equal to 80% of
the VWAP of the shares' five days trading before the conversion notice. On 7 March 2016 DGR Global Ltd and Tenstar Trading
Ltd converted A$2,295,218 of the debt funding derivative provided to SolGold. The conversion was at 3.67 pence (GBP) per
share and generated a movement in fair value on derivative financial liabilities of A$1,378,260 which was expensed to the
income statement in the prior year. 
 
Share and Option transactions of Directors are shown under Notes 5 and 19. 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 22 RELATED PARTIES (continued) 
 
(b) Company 
 
The Company has related party relationships with its subsidiaries (see Note 9), Directors and other key personnel (see
Notes 5 and 19). 
 
All related party transactions are conducted at arm's length. 
 
Subsidiaries 
 
The Company has an investment in subsidiaries balance of A$64,289,892 (2016: A$40,132,827).  The transactions during the
year have been included in note 9.  As the Company does not expect repayment of this amount and will not call payment until
the subsidiary can adequately pay it out of working capital, this amount has been included in the carrying amount of the
investment in the Parent Entity's statement of financial position. 
 
(c)  Controlling party 
 
In the Directors' opinion there is no ultimate controlling party. 
 
NOTE 23 ACCOUNTING ESTIMATES AND JUDGEMENTS 
 
Key sources of estimation uncertainty 
 
The Directors evaluate estimates and judgements incorporated into the financial statements based on historical knowledge
and best available current information.  Estimates assume a reasonable expectation of future events and are based on
current trends and economic data, obtained both externally and within the Group. 
 
Exploration and evaluation expenditure 
 
The Group capitalises expenditure relating to exploration and evaluation where it is considered likely to be recoverable or
where the activities have not reached a stage that permits a reasonable assessment of the existence of reserves.  While
there are certain areas of interest from which no reserves have been extracted, the directors are of the continued belief
that such expenditure should not be written off since feasibility studies in such areas have not yet concluded.  The
Directors have carried out an assessment of the carrying values of deferred exploration and evaluation expenditure and any
required impairment and is included in note 12. 
 
Taxes 
 
Deferred tax assets are recognised for unused tax losses to the extent that it is probable that taxable profit will be
available against which the losses can be utilised.  Significant management judgement is required to determine the amount
of deferred tax that can be recognised, based upon the likely timing and the level of future taxable profits, together with
future tax planning strategies. 
 
The Group has A$86,232,512 (2016: A$65,673,576) of tax losses carried forward.  These losses relate to subsidiaries that
have a history of losses and may not be used to offset taxable income elsewhere in the Group.  The subsidiaries neither
have any taxable temporary difference nor any tax planning opportunities available that could partly support the
recognition of these losses as deferred tax assets.  On this basis, the Group has determined that it cannot recognise
deferred tax assets on the tax losses carried forward.  Further details on taxes are disclosed in note 7. 
 
NOTE 24 CONTINGENT ASSETS AND LIABILITIES 
 
A 2% net smelter royalty is payable to Santa Barbara Resources Limited, who were the previous owners of the Cascabel
tenements.  These royalties can be bought out by paying a total of US$4 million. Fifty percent (50%) of the royalty can be
purchased for US$1 million 90 days following the completion of a feasibility study and the remaining 50% of the royalty can
be purchased for US$3 million 90 days following a production decision. 
 
In the event Cornerstone Capital Resources Inc.'s (Cornerstone) equity interest in ENSA is diluted below 10%, Cornerstone's
equity interest will be converted to a half of one percent (0.5%) interest in a Net Smelter Return and SolGold will have
right to purchase the Net Smelter Return for US$3.5 million at any time. 
 
There are no other contingent assets and liabilities at 30 June 2017 (2016: nil). 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
For the year ended 30 June 2017 
 
NOTE 25 SUBSEQUENT EVENTS 
 
On 7 July 2017, the Company issued an additional 1,300,000 shares at £0.14 to raise A$0.31 million (£0.18 million) in cash
as a result of the exercise of employment options. 
 
On 7 July 2017, the Company issued an additional 1,300,000 shares at £0.28 to raise A$0.62 million (£0.36 million) in cash
as a result of the exercise of employment options. 
 
On 9 August 2017, the Company issued a total of 46,762,000 unlisted options to Directors, employees and contractors. The
options have a strike price of £0.60 each and are exercisable through to 8 August 2020. 
 
On 11 August 2017, the Company issued an additional 690,000 shares at £0.38 to raise A$0.43 million (£0.26 million) to
Newcrest International pursuant to "top-up rights" held by Newcrest International pursuant to the Newcrest Subscription
Agreement. The allotment was price was based on a 10 day VWAP, in accordance with the terms of the Newcrest Subscription
Agreement. 
 
On 29 August 2017, the Company announced that it had been granted an additional 21 new concessions in Ecuador taking the
total number of tenements in Ecuador to 59 tenements in addition to Cascabel. 
 
The Directors are not aware of any other significant changes in the state of affairs of the Group or events after the
reporting date that would have a material impact on the consolidated or Company financial statements. 
 
This information is provided by RNS
The company news service from the London Stock Exchange

Recent news on SolGold

See all news